跳至主要内容
临床试验/NCT05959213
NCT05959213已完成不适用

Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas: a Further Plea for Biological Resectability Criteria.

Fondazione Policlinico Universitario Campus Bio-Medico0 个研究点目标入组 2,034 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,034
主要终点
Quantitative data - Preoperatory levels of CA 19.9 (U/ml)

研究概览

简要总结

In our multicenter retrospective study, preoperative CA 19.9 levels predicts the presence of lymph node metastasis at final histology in patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma .

详细描述

A retrospective analysis have been conducted on more than 2.000 patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma radiologically resectable at the preoperative staging. Preoperatory levels of CA 19.9 were measured in order to identify a relation with nodal involvement at the pathological staging.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergone pancreatoduodenectomy
  • No preoperative radiological suspicion of lymph node metastases.

排除标准

  • Age < 18

结局指标

主要结局

Quantitative data - Preoperatory levels of CA 19.9 (U/ml)

时间窗: 20 years

Define relation of quantitative data (CA 19.9 (U/ml)) with nodal positivity at the final pathological report

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tommaso Farolfi

Principal investigator

Fondazione Policlinico Universitario Campus Bio-Medico

相似试验